Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Choksi AsiaBOM:530427 -0.54%49 Receivables Turnover is 0.98 as of Jun. 2026. GuruFocus rates BOM:530427 with a GF Score™ of 49/100. The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Choksi Asia ranks worse than 62.39% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Choksi Asia's Revenue for the
three
months ended in Jun. 2026 was ₹92.2 Mil. Choksi Asia's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹94.6 Mil.
Hence, Choksi Asia's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.98.
Choksi Asia (BOM:530427) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Choksi Asia Receivables Turnover Related Terms
Choksi Asia Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Choksi Asia's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530427 vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Choksi Asia's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Choksi Asia Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Choksi Asia's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Choksi Asia's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Choksi Asia (BOM:530427) has a Receivables Turnover of 0.98 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Choksi Asia and its competitors. According to the industry distribution chart, Choksi Asia ranks #506 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 62.4%.
Is Choksi Asia's Receivables Turnover too high?
Choksi Asia's current Receivables Turnover is 0.98. The Medical Devices & Instruments industry median Receivables Turnover is 5.58. Choksi Asia's value of 0.98 is 82.4% below this industry median. Based on the distribution chart, Choksi Asia ranks #506 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Choksi Asia has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Choksi Asia ranks #506 out of 811 companies for Receivables Turnover. This places Choksi Asia in the lower half of its industry. The industry median Receivables Turnover is 5.58. Choksi Asia's value of 0.98 is 82.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.58, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Choksi Asia's current Receivables Turnover of 0.98 is 82.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Choksi Asia and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Choksi Asia's current Receivables Turnover is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current Receivables Turnover of 0.98. The current Receivables Turnover is 0.98 and 82.4% below the Medical Devices & Instruments industry median of 5.58. Choksi Asia's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current Receivables Turnover is 0.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
49GF Score
Get the complete analysis for BOM:530427
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530427 has been successfully added to your 
